Detheux Michel — SEC Form 4 filings
SEC reporting owner CIK 1816196. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-12.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-03-08 to 2026-06-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 10 legs across 2 filings — 261,412 shares, $2,640,784 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 40.
- Largest priced transaction: sale of 43,882 shares @ $10.21 ($448,035) in iTeos Therapeutics, Inc., filed 2025-06-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer, Director | 6 | — | 10 legs · 261,412 sh · $2,640,784 | 38 |
| Vor Biopharma Inc. (VOR) | Director | 2 | — | — | 2 |
Form 4 filings — Detheux Michel
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-12 | 4 | Vor Biopharma Inc. (VOR) | Grant/award (A): 57,162 (derivative) @ $0 | EDGAR |
| 2025-08-29 | 4 | iTeos Therapeutics, Inc. (ITOS) | Code (U): 153,903 · Code (U): 94,027 · Disposition to issuer (D): 14,185 (derivative) · Disposition to issuer (D): 444,815 (derivative) · Disposition to issuer (D): 94,336 (derivative) · Disposition to issuer (D): 50,128 (derivative) · +3 more | EDGAR |
| 2025-07-18 | 4 | Vor Biopharma Inc. (VOR) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | iTeos Therapeutics, Inc. (ITOS) | Option exercise (M): 8,400 @ $4.30 · Sale (S): 8,400 @ $10.03 · Option exercise (M): 43,882 @ $4.30 · Sale (S): 43,882 @ $10.03 · Option exercise (M): 8,400 @ $4.30 · Sale (S): 8,400 @ $10.02 · +10 more | EDGAR |
| 2025-06-06 | 4 | iTeos Therapeutics, Inc. (ITOS) | Option exercise (M): 8,400 @ $4.30 · Sale (S): 8,400 @ $10.10 · Option exercise (M): 43,883 @ $4.30 · Sale (S): 43,883 @ $10.10 · Option exercise (M): 8,400 @ $4.30 · Sale (S): 8,400 @ $10.15 · +12 more | EDGAR |
| 2025-03-11 | 4 | iTeos Therapeutics, Inc. (ITOS) | Grant/award (A): 77,000 @ $0 · Grant/award (A): 459,000 (derivative) @ $0 | EDGAR |
| 2024-08-09 | 4 | iTeos Therapeutics, Inc. (ITOS) | Gift (G): 442,800 (derivative) @ $0 · Gift (G): 442,800 (derivative) @ $0 | EDGAR |
| 2024-03-08 | 4 | iTeos Therapeutics, Inc. (ITOS) | Grant/award (A): 590,400 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1816196 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →